HomeInsightsStock Comparison

Emcure Pharmaceuticals Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Emcure Pharmaceuticals Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Last Updated on: Jun 25, 2025

Key Highlights

  • The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1352 as of 25 Jun 10:21.
  • The P/E Ratio of Emcure Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of OneSource Specialty Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Emcure Pharmaceuticals Ltd for the Mar '25 is ₹ 2120 crore as compare to the Dec '24 revenue of ₹ 1959 crore. This represent the growth of 8.23% The revenue of OneSource Specialty Pharma Ltd for the Mar '25 is ₹ 428.84 crore as compare to the Dec '24 revenue of ₹ 399.28 crore. This represent the growth of 7.4%.
  • The ebitda of Emcure Pharmaceuticals Ltd for the Mar '25 is ₹ 396.48 crore as compare to the Dec '24 ebitda of ₹ 358.5 crore. This represent the growth of 10.59% The ebitda of OneSource Specialty Pharma Ltd for the Mar '25 is ₹ 184.72 crore as compare to the Dec '24 ebitda of ₹ 48.08 crore. This represent the growth of 284.19%.
  • The net profit of Emcure Pharmaceuticals Ltd changed from ₹ 140.97 crore to ₹ 197.24 crore over 8 quarters. This represents a CAGR of 18.29% The net profit of OneSource Specialty Pharma Ltd changed from ₹ -107 crore to ₹ 98.5 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Emcure Pharmaceuticals Ltd changed from 25.8 % on March 2020 to 22.53 % on March 2024 . This represents a CAGR of -2.67% over 5 yearsThe Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.

About OneSource Specialty Pharma Ltd

  • Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
  • The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
  • The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
  • Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

Emcure Pharmaceuticals Ltd News Hub

News

Board of Emcure Pharmaceuticals recommends final dividend

Emcure Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:02

News

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

14 May 2025 15:15

News

Emcure Pharma's pune facility receives VAI status from USFDA

The company received the Establishment Inspection Report (EIR) from the USFDA following an...

Read more

21 Apr 2025 11:09

News

Emcure subsidiary Tillomed Laboratories to acquire UK based Manx Healthcare and its subsidiaries

Tillomed Laboratories, a subsidiary of Emcure Pharmaceuticals, has entered into an Asset P...

Read more

04 Apr 2025 12:28

News

Emcure Pharma's European arm acquires Manx Healthcare for '19.7 million

The APA has also been inked with the subsidiaries of Manx, viz. Manx Pharma and Manx Gener...

Read more

04 Apr 2025 14:05

News

Emcutix Biopharmaceuticals inks in-licensing agreement with WiQo

Emcutix Biopharmaceuticals, a wholly owned subsidiary of Emcure Pharmaceuticals, announced...

Read more

02 Apr 2025 10:35

OneSource Specialty Pharma Ltd News Hub

News

OneSource collaborates with Xbrane Biopharma AB

OneSource Specialty Pharma and Xbrane Biopharma AB, a Sweden-headquartered biotechnology c...

Read more

11 Jun 2025 09:07

News

Onesource Specialty edges higher after inking manufacturing pact with biotech firm Xbrane

Xbrane Biopharma AB is a biotechnology company. It develops biological drugs based on a pa...

Read more

11 Jun 2025 10:09

News

OneSource Specialty jumps as Bangalore facility passes USFDA check

The facility received a Voluntary Action Indicated (VAI) classification from the USFDA, fo...

Read more

10 Jun 2025 10:16

News

OneSource receives ratings action from India Ratings & Research

OneSource Specialty Pharma announced that India Ratings & Research has assigned the credit...

Read more

04 Jun 2025 12:48

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

30 Apr 2025 11:35

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

25 Jan 2025 10:23

SWOT Analysis Of OneSource Specialty Pharma Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Emcure Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Emcure Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd

Which company has a larger market capitalization, Emcure Pharmaceuticals Ltd or OneSource Specialty Pharma Ltd?

Market cap of Emcure Pharmaceuticals Ltd is 25,554 Cr while Market cap of OneSource Specialty Pharma Ltd is 22,793 Cr

What are the key factors driving the stock performance of Emcure Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd?

The stock performance of Emcure Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emcure Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd?

As of June 25, 2025, the Emcure Pharmaceuticals Ltd stock price is INR ₹1348.45. On the other hand, OneSource Specialty Pharma Ltd stock price is INR ₹1991.8.

How do dividend payouts of Emcure Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd compare?

To compare the dividend payouts of Emcure Pharmaceuticals Ltd and OneSource Specialty Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions